5-12-2018 15:12:04

KION GROUP overweight

Samenvatting: KION GROUP AG Overweight
Bedrijf:
KION GROUP AG
Analist:
Morgan Stanley
Koersdoel:
68 €
Huidige Rating:
Overweight
Koers*:
51,7599983215332 €
Afstand tot Koersdoel*:
31,3755838583763%
Rating update:
Buy
Laatste koers:
43,97 €
Afstand Koersdoel:
54,6508983397771%
Analist naam::
Ben Uglow
K/W-verhouding*:
-
* Zum Zeitpunkt der Analyse
Meer nieuws

Analisten over KION GROUP AG

14-12-2018 KION GROUP Buy UBS AG
11-12-2018 KION GROUP Buy UBS AG
11-12-2018 KION GROUP Neutral JP Morgan Chase & Co.
7-12-2018 KION GROUP Hold Deutsche Bank AG
6-12-2018 KION GROUP Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
meer analisten

Invoer toevoegen

Aandelen in dit artikel

KION GROUP AG 43,97 -3,93% KION GROUP AG

Laatste Analisten adviezen

14-12-2018 K+S Buy Baader Bank
14-12-2018 ISRA VISION Buy Warburg Research
14-12-2018 McDonalds Overweight JP Morgan Chase & Co.
14-12-2018 Fresenius Medical Care Buy Norddeutsche Landesbank (Nord/LB)
14-12-2018 Cisco Neutral Nomura
14-12-2018 Deutsche Wohnen Outperform Credit Suisse Group
14-12-2018 Lufthansa Outperform Credit Suisse Group
14-12-2018 METRO (St) Hold Independent Research GmbH
14-12-2018 Rio Tinto Neutral Credit Suisse Group
14-12-2018 thyssenkrupp Neutral JP Morgan Chase & Co.
14-12-2018 KION GROUP Buy UBS AG
14-12-2018 RWE Hold Independent Research GmbH
14-12-2018 LANXESS Hold DZ BANK
14-12-2018 LEONI Reduce Kepler Cheuvreux
14-12-2018 METRO (St) Hold Kepler Cheuvreux
14-12-2018 Air Liquide Outperform Bernstein Research
14-12-2018 Dr Hönle Buy Warburg Research
14-12-2018 GlaxoSmithKline Underweight Morgan Stanley
14-12-2018 LEONI Buy Warburg Research
14-12-2018 Merck Morgan Stanley
14-12-2018 Sanofi Morgan Stanley
14-12-2018 LVMH Moet Hennessy Louis Vuitton Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
14-12-2018 Scout24 Neutral JP Morgan Chase & Co.
14-12-2018 AstraZeneca Morgan Stanley
14-12-2018 Novo Nordisk Morgan Stanley
14-12-2018 Novartis Morgan Stanley
14-12-2018 Scout24 Barclays Capital
14-12-2018 Credit Suisse Morgan Stanley
14-12-2018 Commerzbank Morgan Stanley
14-12-2018 Deutsche Bank Underweight Morgan Stanley
14-12-2018 LANXESS Buy Goldman Sachs Group Inc.
14-12-2018 LEONI Buy DZ BANK
14-12-2018 Covestro Neutral Goldman Sachs Group Inc.
14-12-2018 Evonik Neutral Goldman Sachs Group Inc.
14-12-2018 Air Liquide Buy Goldman Sachs Group Inc.
14-12-2018 Givaudan Sell Goldman Sachs Group Inc.
14-12-2018 Symrise Sell Goldman Sachs Group Inc.
14-12-2018 UniCredit Buy UBS AG
14-12-2018 Intesa Sanpaolo Buy UBS AG
14-12-2018 Sanofi Buy Merrill Lynch & Co., Inc.
14-12-2018 Merck Neutral Merrill Lynch & Co., Inc.
14-12-2018 GlaxoSmithKline Neutral Merrill Lynch & Co., Inc.
14-12-2018 Deutsche Telekom RBC Capital Markets
14-12-2018 Roche Overweight Morgan Stanley
14-12-2018 Telefonica Underperform RBC Capital Markets
14-12-2018 Vodafone Group Outperform RBC Capital Markets
14-12-2018 AstraZeneca Buy Merrill Lynch & Co., Inc.
14-12-2018 Facebook Buy Deutsche Bank AG
14-12-2018 Deutsche Börse Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
14-12-2018 AXA Goldman Sachs Group Inc.